Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Goal-directed Blood Pressure Management in Major Abdominal Surgery
NCT03933306Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- May 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in acute kidney injury (AKI) (4 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of organ injury and other complications within 30 days after surgery. Started May 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03933306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03933306.